Navigation Links
Leading Indian CRO 'Max Neeman International' Expands in Response to Positive Biosimilars Market in India
Date:12/5/2011

RESEARCH TRIANGLE PARK, N.C., Dec. 5, 2011 /PRNewswire/ -- A dedicated and experienced Max Neeman team has been set-up to conduct Biosimilar studies for evaluation and efficacy of products. The company expanded into this arena because India has demonstrated the greatest acceptance of Biosimilars reflected by over 50 biopharmaceutical brands getting marketing approval.  CEO, Dr. Ajoy Kumar firmly believes in a responsive, knowledge-based organization to meet client's needs.

(Logo: http://photos.prnewswire.com/prnh/20110105/CL25129LOGO)

The Indian Biosimilars market in 2008 was estimated to be worth approximately $200 million by Universal Consulting [India-based market research firm].  This is forecasted to reach $580 million by 2012 due to two key factors:  relative cost advantage of Biosimilars development versus competitors elsewhere and lower regulatory requirements for establishing bioequivalence [which also helps to keep development costs low].  Currently the manufacture and marketing of Biosimilars in India is governed by the Environment Protection Act of 1970 and the Drugs and Cosmetic Act. 

About Max Neeman International
Max Neeman International is a leading Indian CRO. Our specialty is that we offer services for the successful conduct of Phase II-IV clinical and device trials for small and mid-sized international and national Pharmaceutical, Biotechnology, Medical Device and Nutraceutical companies in compliance with ICH GCP standards. Operational since 2001, Max Neeman is also an ISO 9001:2008 & ISO 27001:2005 certified CRO for Monitoring, Site Management and Data Management Services. The company is presently active in 31 cities with 6 regional offices.   For more information, please contact Donald Swankie, Vice President Business Development at +1.919.424.3345 / donald.swankie@neeman-medical.com or visit www.neeman-medical.com.


'/>"/>
SOURCE Max Neeman International
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Boston Scientific Introduces Industry-Leading ICD and CRT-D Device Warranties
2. Leading Executives Once Again Meet at GDS International’s Next Generation Pharmaceutical Manufacturing Europe Summit to Discuss Key Objectives For The Industry
3. RealTime Medical to Feature Industry-Leading Cross-Platform, Automated Shared Workflow and Dynamic Workflow Assignment Software at RSNA 2011
4. Leading Chemical Weapons Preparedness Companies Announce Partnership to Deploy Break-through Diagnostic Test Internationally
5. PAREXEL Advances Early Phase CNS Research Capabilities With Leading Medical Imaging Technology
6. Qmed, the Leading Global MedTech Industry Resource Announces New Regulatory Tool to Streamline and Simplify the Regulatory and Product Development Process
7. United Spinal Secures Leading Public Policy and Durable Medical Equipment Specialist: Alex Bennewith is New Director of Government Relations
8. Leading Health Organizations and Patient Groups Call for 20 Percent Reduction in Fractures by 2020
9. Patients at Risk for Hepatitis B Are Not Adequately Screened Before Receiving Chemotherapy Leading to the Preventable Reactivation of Hepatitis B Infection
10. The Future of GPCRs in Drug Discovery: Novel technologies, leading companies, and opportunities for target expansion
11. Hypertronics Partners with UBM Canon, the Leading Global Medical Device Industry Source, to Co-Host Strategies for Avoiding Device Failure Seminar
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/11/2016)... 2016 Transformational M&A achieved through NPS ... --> Transformational M&A achieved through NPS and Dyax ... Transformational M&A achieved through NPS and Dyax acquisitions ... for future growth with most robust pipeline in Shire ... future growth with most robust pipeline in Shire , ...
(Date:2/11/2016)... 11, 2016  AbbVie, a global biopharmaceutical company, ... designed to provide financial support for exceptional students ... higher education goals. Fifteen scholars will be selected ... year. The AbbVie Rheumatology Scholarship is currently accepting ... president, corporate social responsibility, brand and communications, AbbVie. ...
(Date:2/11/2016)... Exactus Pharmacy Solutions, a WellCare (NYSE: ... care for those suffering from long-term, life-threatening or ... Specialty Pharmacy Accreditation from URAC, an independent, nonprofit ... care quality through accreditation, education and measurement. ... URAC accreditation process demonstrates a commitment to quality ...
Breaking Medicine Technology:
(Date:2/11/2016)... ... February 11, 2016 , ... “ HEALING MIND : Five ... Managed Mind” (published by Balboa Press) teaches readers how to become their own therapist. ... love, author Janice McDermott, M.Ed., LCSW, offers an understanding of how to heal one’s ...
(Date:2/11/2016)... Jersey (PRWEB) , ... February 11, 2016 , ... Registered ... a free CEU seminar titled, “Stroke Management: Time to Act, Time to Heal” on ... Community in Whippany, N.J. The presenter is Vishal Chedda, president of ANSA Consultants, ...
(Date:2/11/2016)... ... February 11, 2016 , ... Image One USA ... new market, and it’s the buildings of Nashville that will benefit. , “I’ve enjoyed ... to relocate to Nashville, there was no question that I would bring my business ...
(Date:2/11/2016)... ... February 11, 2016 , ... Pediatric cardiovascular surgeons, cardiologists ... by making data on heart procedures public and easily understandable for families and ... Reporting of Pediatric and Congenital Heart Disease Outcomes will bring hundreds of pediatric ...
(Date:2/11/2016)... ... February 11, 2016 , ... veEDIS Clinical Systems, ... with highly adaptable algorithms, has been updated to help Emergency Department physicians and ... consistent with Zikas and a travel history to affected regions, or potential exposure ...
Breaking Medicine News(10 mins):